Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

CompletedOBSERVATIONAL
Enrollment

147

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

October 2, 2024

Study Completion Date

October 2, 2024

Conditions
Heart Transplant
Interventions
DIAGNOSTIC_TEST

Prospera

Monthly testing and results provided

Trial Locations (9)

22042

Inova Heart and Vascular Institute, Falls Church

32224

Mayo Clinic, Jacksonville

37332

Vanderbilt University Medical Center, Nashville

44195

Cleveland Clinic Foundation, Cleveland

60611

Northwestern Memorial Hospital, Chicago

84112

University of Utah, Salt Lake City

90048

Cedars-Sinai Medical Center, Los Angeles

92103

University of California, San Diego, San Diego

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT05309382 - Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation | Biotech Hunter | Biotech Hunter